ATH-1019

N/A

Report date: 2025/03/18 13:50:25

NME

Base Information

Drug NameATH-1019

Drug Alias NameATH-1019

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHepatocyte growth factor stimulantsHepatocyte growth factor receptor agonists

TargetsHepatocyte growth factorHepatocyte growth factor receptor

Therapy Area/IndicationsDiabetic Neuropathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAthira Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDiabetic Neuropathies

Inactive IndicationsN/A

ATC CodeN/A